Viridian Therapeutics, Inc. VRDN Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s other non-current liabilities?
- Viridian Therapeutics, Inc. (VRDN) reported other non-current liabilities of $2.18M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s other non-current liabilities changed year-over-year?
- Viridian Therapeutics, Inc.'s other non-current liabilities increased by 15.5% year-over-year, from $1.88M to $2.18M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s other non-current liabilities has grown at a 122.4% compound annual growth rate (CAGR), from $43K to $2.34M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.